Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Sundry Debtors ₹1,858 Cr₹3,665 Cr₹3,101 Cr₹2,572 Cr₹2,409 Cr

What is the latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS ?

The latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS is ₹1,858 Cr based on Mar2024 Consolidated results.
Year Sundry Debtors
Mar2024₹1,858 Cr
Mar2023₹3,665 Cr
Mar2022₹3,101 Cr
Mar2021₹2,572 Cr
Mar2020₹2,409 Cr

How is Sundry Debtors of GLENMARK PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2024 ₹1,858 Cr
-49.30
Mar2023 ₹3,665 Cr
18.19
Mar2022 ₹3,101 Cr
20.57
Mar2021 ₹2,572 Cr
6.77
Mar2020 ₹2,409 Cr -

Compare Sundry Debtors of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,810.4 Cr 3.7% 5% 40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

5%

40.9%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses